FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

44062011000036105: Survanta (beractant 200 mg / 8 mL) intratracheal suspension, 1 x 8 mL vial (containered trade product pack)


Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
530381000036118 Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial en Synonym Active Case sensitive Australian Medicines Terminology module
530391000036116 Survanta (beractant 200 mg / 8 mL) intratracheal suspension, 1 x 8 mL vial (containered trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial Is a containered trade product pack true Inferred relationship Some
Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial Is a Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial true Inferred relationship Some
Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial has container type vial true Inferred relationship Some
Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial has TPUU Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial true Inferred relationship Some 1
Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial has TP Survanta true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)

Australian dialect reference set

Description inactivation indicator reference set

Containered trade product pack reference set

Back to Start